Léim ar aghaidh chuig an bpríomhábhar
Gnáthamharc

Medicinal Products

Dáil Éireann Debate, Tuesday - 21 April 2026

Tuesday, 21 April 2026

Ceisteanna (751)

Ken O'Flynn

Ceist:

751. Deputy Ken O'Flynn asked the Minister for Health whether any internal audit, external audit, or value-for-money review has been conducted in respect of expenditure by the Primary Care Reimbursement Service on salbutamol nebules under the general medical services scheme since January 2024; if so, to provide the dates and findings of such reviews; and if not, the reason none has been undertaken. [28038/26]

Amharc ar fhreagra

Freagraí scríofa

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines and medical devices; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.

Roinn